{'fraction_non_alphanumeric': 0.014527845036319613, 'fraction_numerical': 0.0, 'mean_word_length': 5.778688524590164, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Should Radiofrequency Denervation Be Dropped From the Clinical Arsenal for Chronic Back Pain?

Three randomized controlled trials (RCTs) from the Netherlands have concluded that a common treatment for chronic low back pain—radiofrequency denervation (RFDN) of nerves supplying spinal joints—does not have any clinically significant impact on pain and disability and should be dropped from the standard clinical arsenal. The studies are the product of a promising new model for evaluating the effectiveness and cost-effectiveness of treatments new and old. This innovative approach may speed the introduction of new treatments into clinical practice and weed out many marginal treatments that do not deserve continuing reimbursement. Should Radiofrequency Denervation Be Dropped From the Clinical Arsenal for Chronic Back Pain?